Literature DB >> 32208321

A novel circular RNA (hsa_circRNA_102336), a plausible biomarker, promotes the tumorigenesis by sponging miR-515-5p in human bladder cancer.

Pengfeng Gong1, Renfang Xu1, Qianfeng Zhuang1, Xiaozhou He2.   

Abstract

Bladder cancer (BC) ranks as the ninth common human tumor in the world with an increasing incidence. Circular RNAs (circRNAs) have been revealed to exhibit promotive or suppressive impacts on tumor progression of various human cancers, including BC. However, due to the variety of circRNAs, the whole circRNAs network in BC remains unclear. In our study, differentially expressed circRNAs between BC and normal samples in GSE92675 dataset was analyzed by microarray. Circ_102336 was identified to be sharply increased in both BC tissue samples and cell lines, and increased circ_102336 is correlated with a worse overall survival rate of BC patients. Overexpression of circ_102336 dramatically increased the cell proliferation viability of T24 and 5637 cells, while knockdown of circ_102336 exhibited opposite effects. Moreover, circ_102336 knockdown could increase the sensitivity of T24 and 5637 cells to CDDP. In mechanism, circ_102336 was demonstrated to directly bind to and negatively regulate miR-515-5p. Inhibition of miR-515-5p reversed the repressive effects of si-circ_102336 on BC cell proliferation viability. KEGG analysis showed that ATP-binding cassette (ABC) transporters and apoptosis were the major two pathways associated with circ_102336/miR-515-5p axis. therefore, we suggested that circ_102336 indirectly regulate apoptosis and ABC transport pathways through miR-515-5p to finally modulate BC cell proliferation and chemo-resistance.
Copyright © 2020. Published by Elsevier Masson SAS.

Entities:  

Keywords:  ATP-binding cassette transporters; Bladder cancer; Chemo-resistance; circ_102336; miR-515-5p

Mesh:

Substances:

Year:  2020        PMID: 32208321     DOI: 10.1016/j.biopha.2020.110059

Source DB:  PubMed          Journal:  Biomed Pharmacother        ISSN: 0753-3322            Impact factor:   6.529


  8 in total

Review 1.  Circular RNAs and Drug Resistance in Genitourinary Cancers: A Literature Review.

Authors:  Gongwei Long; Siquan Ma; Runlin Shi; Yi Sun; Zhiquan Hu; Ke Chen
Journal:  Cancers (Basel)       Date:  2022-02-09       Impact factor: 6.639

2.  Circular RNA circ_0032821 contributes to oxaliplatin (OXA) resistance of gastric cancer cells by regulating SOX9 via miR-515-5p.

Authors:  Yanmei Zhong; Dan Wang; Yanle Ding; Guixin Tian; Bing Jiang
Journal:  Biotechnol Lett       Date:  2020-10-29       Impact factor: 2.461

3.  circCEP128 Knockdown Suppresses Bladder Cancer Progression via Regulating microRNA-515-5p/SDC1 Axis.

Authors:  Guanghui Cao; Chan Zhang; Xiangyong Tian; Gaopeng Jing; Xiaolin Zhou; Tianzhong Yan
Journal:  Cancer Manag Res       Date:  2021-03-29       Impact factor: 3.989

4.  Effect of miR-515-5p on Proliferation and Drug Sensitivity of Retinoblastoma Cells.

Authors:  Xiang Wen Yuan; Ting Qin Yan; Huilin Tong
Journal:  Cancer Manag Res       Date:  2020-11-24       Impact factor: 3.989

5.  Circ_0020123 enhances the cisplatin resistance in non-small cell lung cancer cells partly by sponging miR-140-3p to regulate homeobox B5 (HOXB5).

Authors:  Dong Wei; Jing Zeng; Feng Rong; Yasheng Xu; Rong Wei; Can Zou
Journal:  Bioengineered       Date:  2022-03       Impact factor: 3.269

Review 6.  The Role of Circular RNAs in the Carcinogenesis of Bladder Cancer.

Authors:  Soudeh Ghafouri-Fard; Sajad Najafi; Bashdar Mahmud Hussen; Abbas Basiri; Hazha Jamal Hidayat; Mohammad Taheri; Fariborz Rashnoo
Journal:  Front Oncol       Date:  2022-02-28       Impact factor: 6.244

7.  Hsa_circ_0003221 facilitates the malignant development of bladder cancer cells via resulting in the upregulation of DHCR24 by targeting miR-892b.

Authors:  Peng Lu; Yingchun Jiang; Zongyu Xia
Journal:  Investig Clin Urol       Date:  2022-09

8.  Circular RNA TAF4B Promotes Bladder Cancer Progression by Sponging miR-1298-5p and Regulating TGFA Expression.

Authors:  Xiaoting Zhang; Xiaofeng Li; Xian Fu; Mengli Yu; Guicheng Qin; Guihong Chen; Chenchen Huang
Journal:  Front Oncol       Date:  2021-07-12       Impact factor: 6.244

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.